GO | Name |
GO:0001798 | positive regulation of type IIa hypersensitivity |
GO:0001934 | positive regulation of protein phosphorylation |
GO:0001970 | positive regulation of activation of membrane attack complex |
GO:0004866 | endopeptidase inhibitor activity |
GO:0005576 | extracellular region |
GO:0005615 | extracellular space |
GO:0006631 | fatty acid metabolic process |
GO:0006954 | inflammatory response |
GO:0006956 | complement activation |
GO:0006957 | complement activation, alternative pathway |
GO:0006958 | complement activation, classical pathway |
GO:0007596 | blood coagulation |
GO:0008289 | lipid binding |
GO:0009617 | response to bacterium |
GO:0009986 | cell surface |
GO:0010575 | positive regulation of vascular endothelial growth factor production |
GO:0010828 | positive regulation of glucose transmembrane transport |
GO:0010866 | regulation of triglyceride biosynthetic process |
GO:0010884 | positive regulation of lipid storage |
GO:0016322 | neuron remodeling |
GO:0031715 | C5L2 anaphylatoxin chemotactic receptor binding |
GO:0032991 | protein-containing complex |
GO:0035846 | oviduct epithelium development |
GO:0045745 | positive regulation of G protein-coupled receptor signaling pathway |
GO:0045766 | positive regulation of angiogenesis |
GO:0048260 | positive regulation of receptor-mediated endocytosis |
GO:0048639 | positive regulation of developmental growth |
GO:0050766 | positive regulation of phagocytosis |
GO:0060100 | positive regulation of phagocytosis, engulfment |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade |
GO:0097242 | amyloid-beta clearance |
GO:0097278 | complement-dependent cytotoxicity |
GO:0150062 | complement-mediated synapse pruning |
GO:0150064 | vertebrate eye-specific patterning |
GO:1905114 | cell surface receptor signaling pathway involved in cell-cell signaling |
GO:2000427 | positive regulation of apoptotic cell clearance |